EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach

Yi Wang, Tong Zhao, Chuyue Huang, Fei Liu, Yang Zhang, Desong Kong, Zhimin Fan

Phytomedicine · 2024-01 · 123 · 155174

DOI: 10.1016/j.phymed.2023.155174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-01. Verfasst von Yi Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Colon and Rectal Surgery, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Colorectal Neoplasms. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Banxia Xiexin decoction (BXD) is a traditional Chinese medicine with anti-colorectal cancer (CRC) activity. However, its bioactive constituents and its mechanism of action remain unclear. Herein, we explored the mechanism of action of BXD against CRC using a network pharmacology approach. METHODS: First, the targets of the main chemical components of BXD were predicted and collected through a database, and the intersection of compound targets and disease targets was obtained. Subsequently, protein-protein interaction network analysis, Gene Ontology enrichment, and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed to explore the potential mechanisms underlying the effects of BXD on CRC. Finally, a CRC cell model and a CRC xenograft model in nude mice were utilized to further determine the mechanism of action. RESULTS: A compound-therapeutic target network of BXD was constructed, revealing 146 cellular targets of BXD. The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling axis was identified as the main target of BXD. Using in vitro and in vivo models, the activity of BXD against CRC was found to be mediated through ferritinophagy by targeting the PI3K/AKT/mTOR axis, leading to intracellular iron accumulation, reactive oxygen species activation, and finally ferroptosis. CONCLUSIONS: Through the application of network pharmacology and in vitro/in vivo validation experiments, we discovered that BXD exerts anti-CRC effects via the ferritinophagy pathway. Furthermore, we elucidated the potential mechanism underlying its induction of ferritinophagy. These findings demonstrate the significant potential of traditional drugs in managing CRC and support their wider clinical application in combination chemotherapy, targeted therapy, and immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalColorectal NeoplasmsAnimalsMiceHumansPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktMice, NudeNetwork PharmacologyPhosphatidylinositol 3-KinaseTOR Serine-Threonine KinasesMolecular Docking SimulationMammals

Stichwörter der Autor:innen

Banxia Xiexin decoctionColorectal cancerNetwork pharmacologyPI3K/AKT/mTOR

Substanzen

banxia xiexin decoctionPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktDrugs, Chinese HerbalPhosphatidylinositol 3-KinaseTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Colon and Rectal Surgery, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China.
  • School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Clinical Innovation Center For Anorectal Diseases of T.C.M, Nanjing H…
  • Colon and Rectal Surgery, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China. Electronic address: 21670235@qq.com.
  • Chinese Medicine Modernization and Big Data Research Center, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China; Jiangsu Clinical Innovation Center For Anore…
  • Colon and Rectal Surgery, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China; Jiangsu Clinical Innovation Center For Anorectal Diseases of T.C.M, Nanjing Hos…

Zitieren

APA

Wang, Y., Zhao, T., Huang, C., Liu, F., Zhang, Y., Kong, D., & Fan, Z. (2024). Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach. Phytomedicine, 123, 155174. https://doi.org/10.1016/j.phymed.2023.155174

Vancouver

Wang Y, Zhao T, Huang C, Liu F, Zhang Y, Kong D, et al. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach. Phytomedicine. 2024;123:155174. doi:10.1016/j.phymed.2023.155174

BibTeX
@article{Wang2024,
  author = {Wang, Yi and Zhao, Tong and Huang, Chuyue and Liu, Fei and Zhang, Yang and Kong, Desong and Fan, Zhimin},
  title = {Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach},
  journal = {Phytomedicine},
  year = {2024},
  volume = {123},
  pages = {155174},
  doi = {10.1016/j.phymed.2023.155174}
}
Kostenlos starten →